Grey Matters Health Inc. (CSE: GREY) announced on November 16, 2026 that its flagship NovaScan Neuroimaging Clinics™ location in Davie, Florida has received accreditation and completed full enrollment in both U.S. Medicare and Medicaid programs. The company describes the milestone as a major commercial development, as accreditation is a prerequisite for Medicare and Medicaid reimbursement and for negotiating in-network contracts with most private insurers. Investors may be watching closely, as the milestone opens the clinic's brain PET scanning services to a broad base of eligible American patients.
Key Points
- Grey Matters Health Inc. (CSE: GREY, Frankfurt: AGW0, OTC: AGNPF) is a Canadian healthcare company focused on brain dedicated PET scanning services.
- The flagship NovaScan Neuroimaging Clinics™ location at HCA Florida University Medical Office Building in Davie, Florida has received accreditation and completed Medicare and Medicaid enrollment.
- Brain PET scans for beta-amyloid plaque detection associated with Alzheimer's disease are covered by Medicare, Medicaid, and most private insurance for patients aged 65 and older.
- Investors should watch for updates on private insurer in-network contract negotiations and the company's broader U.S. clinic expansion progress.
Accreditation Unlocks Medicare, Medicaid, and Private Insurer Access
Under U.S. regulations, all diagnostic imaging centres must be accredited by one of four governing bodies before they can receive Medicare or Medicaid payments or negotiate in-network contracts with most private insurers. The accreditation process, as described in the release, reviews radiation dose control protocols, diagnostic image quality, and staff qualifications including licensing and ongoing training. By satisfying these requirements, the Davie clinic can now bill under established codes for both brain PET scans and the isotopes used in the imaging procedure.
NovaScan Neuroimaging Clinics™ Davie Site and CareMiBrain™ Technology
The Davie location, situated on the campus of HCA Florida University Hospital, is described in the release as the first clinic of its kind in the United States to offer brain dedicated PET scans specifically aimed at aiding detection of Alzheimer's disease and other neurodegenerative conditions. The clinic features the U.S. FDA-cleared CareMiBrain™ system, a dedicated brain PET scanner with a chair-styled design that does not require an integrated CT component, resulting in what the company states is 25% less radiation exposure for patients compared to conventional systems.
Grey Matters CEO Outlines Commercialisation Message for Doctors and Patients
Grey Matters CEO Christopher J. Moreau stated in the release that the company has reached a stage in its commercialisation pathway where it can begin introducing doctors and patients to the clinic's features, including its brain dedicated PET scan technology. Moreau highlighted advanced image resolution for earlier diagnosis and an enhanced patient experience as central elements of the company's service offering, with the stated aim of establishing a chain of dedicated brain PET imaging clinics across the United States. The company did not disclose financial projections or a specific clinic expansion timeline in the announcement.




Please wait processing your request...